The inhibitory effects of plumbagin on the NF-қB pathway and CCL2 release in racially different triple-negative breast cancer cells

Breast cancer (BC) is the second leading cause of death among women in the US, and its subtype triple-negative BC (TNBC) is the most aggressive BC with poor prognosis. In the current study, we investigated the anticancer effects of the natural product plumbagin (PL) on racially different TNBC cells....

Descripción completa

Detalles Bibliográficos
Autores principales: Messeha, Samia S., Zarmouh, Najla O., Mendonca, Patricia, Alwagdani, Hayfaa, Kolta, Malak G., Soliman, Karam F. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066199/
https://www.ncbi.nlm.nih.gov/pubmed/30059519
http://dx.doi.org/10.1371/journal.pone.0201116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066199/
https://www.ncbi.nlm.nih.gov/pubmed/30059519
http://dx.doi.org/10.1371/journal.pone.0201116

Ejemplares similares